Results 111 to 120 of about 3,876,682 (209)

Expression of M30 and M65 in celiac disease. Analytical cross-sectional study

open access: yesSão Paulo Medical Journal
BACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease ...
Evrim Kahramanoğlu Aksoy   +6 more
doaj   +1 more source

Tissue transglutaminase is the target in both rodent and primate tissues for celiac disease-specific autoantibodies

open access: yes, 2000
Background: Endomysial antibodies have recently been shown to react with tissue transglutaminase. This study was undertaken to investigate whether the tissue distribution of transglutaminase is also compatible with reticulin, jejunal, and fibroblast ...
Sulkanen   +17 more
core   +2 more sources

Intestinal tissue transglutaminase in coeliac disease of children and adults : Ultrastructural localization and variation in expression

open access: yes, 2004
Background: Tissue transglutaminase is the main antigen for the anti-endomysial antibodies used for diagnosis of coeliac disease and can with some specificity in vitro deamidate gliadins generating potent epitopes.
Skovbjerg, H,   +17 more
core   +1 more source

Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture

open access: yes, 2019
Potential celiac disease is characterized by positive results from serologic tests for tissue transglutaminase antibodies (anti-TG2) but normal duodenal architecture (Marsh stages 0-1). There is controversy over the best way to manage these patients.
Cielo D.   +10 more
core   +1 more source

Tissue Transglutaminase Inhibition

open access: yes, 2005
Khosla and coworkers report the synthesis of peptidic dihydroisoxazole derivatives, the in vitro evaluation of these novel compounds as inhibitors of recombinant human tissue transglutaminase (TG2), and their oral bioavailability and efficacy for the ...
Keillor, Jeffrey W.
core   +1 more source

New Serology Assays Can Detect Gluten Sensitivity among Enteropathy Patients Seronegative for Anti-Tissue Transglutaminase

open access: yes, 2010
BACKGROUND: Some patients with celiac disease ( CD) may be seronegative with the commonly used test for IgA anti-tissue transglutaminase (anti-tTG) antibodies. Our aim was to explore whether newer assays incorporating synthetic deamidated gliadin-related
Binder, W.   +21 more
core   +1 more source

Comparison of tissue transglutaminase and anti-endomysial antibody tests in diagnosis of celiac disease

open access: yes, 2020
Background: Although initially considered as a digestive tract disease, celiac disease (CD) can cause problems and complications in most other organs.
Sohrabi, A., Shahmirzadi, M.S.
core  

Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease

open access: yes, 2007
Background Our aim was to understand why some sera from patients with a broad spectrum of autoimmune diseases or non-autoimmune diseases involving enhanced apoptosis, cell lysis and/or putative secondary autoimmune processes show reactions in the tissue ...
Tox U   +23 more
core   +1 more source

Home - About - Disclaimer - Privacy